Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Metacrine Secures $36 Million In Financing

    Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Surge Invests In Elite Clinical Network

    Surge Private Equity has announced it has invested in Elite Clinical Network (ECN) in a transaction valued at around $200 million.
    United StatesFood, Drugs, Healthcare, Life Sciences
McGuireWoods LLP
McGuireWoods LLP
  • Article

    Healthcare Legislation Outlook And Update

    In this memorandum, Holland & Knight's Healthcare & Life Sciences Team summarizes recent U.S. Senate action on healthcare legislation and provides an outlook on upcoming issues and possible actions.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Holland & Knight
    Holland & Knight
  • Article

    House Passes FDA User Fee Bill; Congress on Track to Pass Reconciled Bill by Beginning of July

    The U.S. House of Representatives passed the Food and Drug Administration Reform Act of 2012.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    House Subcommittees Will Hold Hearing On "Pursuing The Golden Age Of Innovation: Strategic Priorities In Biotechnology" On June 5

    On June 5, 2025, the House Science and Technology Subcommittees on Energy and on Research and Technology will hold a joint hearing on "Pursuing the Golden Age of Innovation: Strategic Priorities in Biotechnology."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bergeson & Campbell
    Bergeson & Campbell
  • Article

    Howard Sklamberg Discusses FDA's Ban On Red Dye No. 3 On Public Health On Call Podcast

    Life Sciences & Healthcare Regulatory partner Howard Sklamberg was recently featured on the Public Health on Call podcast episode, "The FDA Says Goodbye to Red Dye No. 3," produced...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    IBA Agriculture And Food Section And Healthcare And Life Sciences Law Committee Virtual Joint Networking Session, March 20, 2025, 15:00-16:00 (GMT), Via Webinar

    The International Bar Association (IBA) Agriculture and Food Section (AFS) and Healthcare and Life Sciences Law Committee are pleased to invite other lawyers interested in agriculture, food...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bergeson & Campbell
    Bergeson & Campbell
  • Article

    Inconsistency Among Courts Regarding Pleading Standards For Parallel Claims Involving Medical Devices

    Inconsistency Among Courts Regarding Pleading Standards for Parallel Claims Involving Medical Devices.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Duane Morris LLP
    Duane Morris LLP
  • Article

    Industry Fights Back Against Restrictions On Pharmaceutical Manufacturers' Ability To Offer Drug Cost-Sharing Subsidies

    Pharmaceutical manufacturers and lobbying groups are challenging these administrative restrictions in a concerted effort to increase access to life-saving medications.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Sheppard
    Sheppard
  • Article

    Influencer Promo Guide: Best Practices For Drug And Device Firms

    All companies must be mindful of compliance with Federal Trade Commission (FTC) guidelines for influencers and marketers,
    United StatesFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    Insurance Coverage For False Claims Act Lawsuits?

    The number of qui tam actions brought under the False Claims Act has increased dramatically over the past several years, as the incentives for bringing such claims have grown
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    ISO Publishes Standards For Graphene-Related 2D Materials

    The International Organization for Standardization (ISO) recently published two standards for graphene-related two-dimensional (2D) materials...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bergeson & Campbell
    Bergeson & Campbell
  • Article

    It's About Time (But Not Quite Yet)

    When misconduct occurs within an organization, it is often reported and interpreted as an anecdote involving a few rogue employees who are quickly identified and appropriately disciplined.
    United StatesFood, Drugs, Healthcare, Life Sciences
    BakerHostetler
    BakerHostetler
  • Article

    Kansas Recovers $27.6 Million From Pharmacy Benefit Manager For Alleged Overbilling Of Medicaid

    Kansas AG Derek Schmidt reached a settlement with pharmacy benefit manager Centene Corp. and its subsidiaries (collectively "Centene")
    United StatesFood, Drugs, Healthcare, Life Sciences
    Cozen O'Connor
    Cozen O'Connor
  • Article

    Kessel And Masella Write Article On Helping Biotechs Prepare For Crises

    How can you prepare for the day when an unexpected event morphs into a crisis, with all the potential negative repercussions for your company's reputation and financial standing?
    United StatesFood, Drugs, Healthcare, Life Sciences
    A&O Shearman
    A&O Shearman
  • Article

    Key Considerations For Food Safety Recalls

    Steptoe partners Joseph Dages, Ryan Poscablo, and Anthony Anscombe and associate Emma Howard authored an article titled "Key Considerations for Food Safety Recalls," which appeared in Food Safety Magazine.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Steptoe LLP
    Steptoe LLP
  • Article

    Key Takeaways From FDLI's Enforcement, Litigation, And Compliance Conference Keynote Address

    FDLI hosted a virtual conference December 9–10, 2021. The keynote address was given by Arun Rao, Deputy Assistant Attorney General at the United States Department of Justice (DOJ).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Morrison Foerster
    Morrison Foerster
  • Article

    Kracov Featured In Law360 Q&A On Pandemic Ramifications For US Health Care System

    Arnold & Porter partner Daniel Kracov, co-chair of the firm's Life Sciences and Healthcare Regulatory practice, was recently featured in a Law360 profile ...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Kroger Agrees To Pay $1.37 Billion To State Attorneys General In Opioid Settlement

    On Monday, November 4, supermarket chain Kroger finalized a settlement agreement with dozens of state attorneys general requiring the company to pay a total of $1.37 billion...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Duane Morris LLP
    Duane Morris LLP
  • Video

    Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Video)

    We are excited to begin In the Public Interest's sixth season with the introduction of our new cohost Jekkie Kim. Jekkie is a corporate partner in WilmerHale's Palo Alto office...
    United StatesFood, Drugs, Healthcare, Life Sciences
    WilmerHale
    WilmerHale
  • Showing 481–500 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics